WO2001030423A1 - Cartouche de medicament - Google Patents
Cartouche de medicament Download PDFInfo
- Publication number
- WO2001030423A1 WO2001030423A1 PCT/US2000/029111 US0029111W WO0130423A1 WO 2001030423 A1 WO2001030423 A1 WO 2001030423A1 US 0029111 W US0029111 W US 0029111W WO 0130423 A1 WO0130423 A1 WO 0130423A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stopper
- medicament
- needle
- tubular member
- medicament cartridge
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/285—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
- A61M5/286—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened upon internal pressure increase, e.g. pierced or burst
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M2005/31516—Piston or piston-rod constructions, e.g. connection of piston with piston-rod reducing dead-space in the syringe barrel after delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
Definitions
- the present invention is directed to a device for delivery of medicament, and in particular to a medicament cartridge for use with a medicament injector, such as a syringe or needle assisted jet injector.
- a medicament injector such as a syringe or needle assisted jet injector.
- Medicament cartridge having three stoppers are useful for a number of applications, including separation of the needle from a colloid or particulate drug until injection to prevent needle clogging.
- Three stopper designs can be used in any situation in which there is reason not to have the needle bearing stopper in contact with the drug prior to the injection. This could be required for drug stability reasons - either because the drug was inherently unstable or because stability data existed for the drug but without a needle.
- a first stopper is located at one end of the medicament cartridge with an end of the needle protruding from both sides of the stopper.
- the second stopper is located at the other end of the medicament cartridge and the third stopper is located between the first and second stoppers, with the medicament filling the space between the second and third stoppers.
- an energy mechanism urges the second stopper toward the first stopper. This movement results in the creation of fluid pressure due to incompressibility of the medicament.
- This fluid pressure forces the third stopper toward the first stopper causing the needle end to puncture the third stopper, thereby creating a fluid pathway for the medicament.
- An inherent challenge to the three stopper design is the complexity added to the manufacturing process, and in particular, to aseptically filling the medicament cartridge.
- the requirement for placing all three stoppers in specific locations will add both handling complexity and costs to the process.
- a major concern associated with handling complexity associated with aseptic filling is that every manipulation step is a potential for introducing contamination. Having a significant amount of failure due to contamination represents a large health and economic risk to the filler.
- An additional complication to three stopper designs in which one stopper contains a double ended needle is the handling of the needle-stopper combination after it is manufactured. In some commercially available designs, the designs anticipate sterilization after manufacture followed by shipment in appropriate containers to the filling facility. Packaging of such an article with two sharp needle ends is complicated.
- the needle points have to be preserved in their manufactured form to be functionally optimal. Also, the handling of such needles by manual assembly processes or by automated processes requires packaging to allow safe shipment and handling. This adds complexity and cost to the piece in addition to adding the complexity of requiring the packaging to be removed as part of the final device assembly process.
- the present invention relates to a medicament cartridge for an injection device for delivering a medicament.
- the medicament cartridge according to the present invention comprises a tubular member having first and second ends and a lumen with a longitudinal axis for retaining the medicament therein, a needle operatively associated with the second end of the tubular member and having a piercing end, a first stopper located within the lumen near the first end of the tubular member and moveable within the lumen along the longitudinal axis, and a flexible member located within the lumen near the second end of the tubular member and covering the piercing end of the needle. Relative movement between the first stopper and the flexible member compresses the medicament and urges the flexible member toward the second end of the tubular member such that the piercing end of the needle pierces the flexible member to create a fluid pathway for the medicament through the needle.
- the relative movement between the first stopper and the flexible member results from the first stopper moving toward the second end of the tubular member to compress the medicament.
- the needle is located in a second stopper with the piercing end extending from the second stopper and at least a portion of the second stopper inserted in the lumen near the second end of the tubular member.
- the piercing end of the needle can be beveled to facilitate puncturing the flexible member.
- the flexible member is a flexible membrane attached to the second stopper with at least a portion of the flexible membrane located between the second stopper and the tubular member.
- the second stopper can include a first section with a wall defining a cavity having an opening and the first stopper has a medicament contacting surface configured and dimensioned to mate with the opening of the cavity to minimize volume of medicament remaining in the lumen after the first stopper has reached the second end of the tubular member.
- the shape of the cavity can be frustroconical or any other suitable configuration.
- the second stopper can also include a second section extending beyond the tubular member and a shoulder located between the first and second sections of the second stopper and contacting the second end of the tubular member.
- the needle can have an injecting tip opposite the piercing end and the medicament cartridge can include a needle guard covering this injecting tip.
- the needle guard has an enlarged end larger than the opening of the cavity of the second stopper or the needle guard is configured and dimensioned to be insertable in the opening without contacting the needle.
- the flexible member comprises a cap and a base with a collapsible portion that flexes upon compression of the flexible member.
- the first stopper has a medicament contacting surface and the cap has a surface with a dimple configured and dimensioned to mate with at least a portion of the medicament contacting surface to minimize volume of medicament remaining in the lumen after the first stopper has reached the second end of the tubular member.
- the piercing end of the needle pierces the dimpled surface of the cap.
- Figure 1 is a cross sectional view of an embodiment of the medicament cartridge according to the present invention.
- Figure 2 is a cross sectional view of the medicament cartridge of Figure 1 upon activation of an energy mechanism to commence an injection
- Figure 3 is a cross sectional view of the medicament cartridge of Figure 1 near completion of the injection
- Figure 4 is a cross section view of a portion of the medicament cartridge of Figure 1 prior to completion of assembly (e.g. without a flexible member covering the needle) and fill;
- Figure 5 is a cross sectional view of another embodiment of the medicament cartridge according to the present invention.
- Figure 6 is a cross sectional view of the medicament cartridge of Figure 5 upon activation of an energy mechanism to commence an injection
- Figure 7 is a cross sectional view of the medicament cartridge of Figure 5 near completion of the injection.
- a medicament cartridge 10 comprises a tubular member 12 having a distal or first end 14 and a proximal or second end 16.
- proximal and distal are used with respect to the injection site so that distal or first end 14 is the end of tubular member 12 farthest from the injection site and the proximal or second end 16 is nearest to the injection site.
- Tubular member 12 defines a lumen 18 that has a cylindrical shape with a longitudinal axis.
- lumen 18 will be in contact with the medicament. Therefore, tubular member 12 should be made of a material compatible with the medicament.
- the walls of lumen 18 could be coated with such a material.
- An example of a material known to be compatible with most medicaments is borosilicate glass and other examples of suitable materials are well known to those of ordinary skill in the art.
- a needle 20 is operatively associated with second end 16 of tubular member 12. Needle 20 has a piercing end 22 that extends into lumen 18 and, in an exemplary embodiment, an injecting tip 24 extending beyond second end 16 of tubular member 12 and inserted into the person receiving the injection.
- the length of injecting tip 24 can be selected based on the injection device and particular application that cartridge 10 is intended for use with. For example, if the injection device is a conventional auto-injector, the length of injecting tip 24 should be at least about 5 mm. If the injection device is a needle-assisted jet injector, the length of injecting tip 24 is about 5 mm or less. If the injection device is a jet injector, then injecting tip 24 does not extend substantially beyond second end 16.
- a sheath or needle cap 25 typically covers injecting tip 24 to keep it clean and free from debris. Prior to use, the sheath is removed.
- Cartridge 10 also has a flexible member, a flexible membrane 26, that covers piercing end 22 of needle 20. When cartridge 10 is assembled and filled, membrane 26 is located within lumen 18 near second end 16 of tubular member 12. The medicament in lumen 18 is located between membrane 26 and a first stopper 28, which is near first end 14 of tubular member 12. As membrane 26 covers piercing end 22 of needle 20, membrane 26 prevents contact between the medicament and needle 20 until use. Membrane 26 also protects piercing end 22 against contamination during manufacturing and fill of cartridge 10.
- needle 20 is located in a second stopper 30 with piercing end 22 extending from second stopper 30 and at least a portion of the second stopper 30 inserted in lumen 18 near second end 16 of tubular member 12. Injecting tip 24 extends beyond second end 16 of tubular member 12.
- Second stopper 30 comprises a first section 32 with a wall 34 defining a cavity 36. Cavity 36 is shown having a frustroconical shape, although other shapes are envisioned within the scope of the current invention.
- Piercing end 22 of needle 20 extends into cavity 36.
- the sliding of first stopper 28 in lumen 18 toward second end 16 of tubular member 12 expels medicament from lumen 18 through needle 20, i.e. injection of the medicament.
- first stopper 28 has a medicament contacting surface 38 that mates with cavity 36 as best seen in FIG. 3.
- Second stopper 30 also has a second section 40 that extends beyond tubular member 12.
- a shoulder 42 contacts second end 16 of tubular member 12 and is located between first and second sections 32, 40 of second stopper 30.
- membrane 26 can be attached or otherwise affixed to second stopper 30 either before needle 20 is inserted into second stopper 30 or shortly thereafter. Once assembled, at least a portion of membrane 26 is located between first section 32 of second stopper 30 and tubular member 12. As previously noted, membrane 26 prevents contact between the medicament and needle 20 until use and protects piercing end 22 against contamination during manufacturing and fill of cartridge 10.
- needle cap 25 is configured and dimensioned so that even prior to placement of flexible membrane 26 to cover piercing end 22, there is no risk of contact with piercing end 22.
- needle cap 25 has an enlarged end 44 that has a width or diameter (w) that is larger than the width or diameter (o) of cavity 36 shielding piercing end 22 of needle 20.
- the depth (d) that needle 20 is recessed in cavity 36 is chosen so that enlarged end 42 cannot contact any part of needle 20.
- the other dimensions of cartridge 10 have also been selected such that protruding features cannot extend deep enough into cavity 36 to damage or impinge piercing end 22.
- the width and length of wall 34 and shoulder 42 are selected such that neither wall 34 or shoulder 42 can extend into cavity 36 to come in contact with any part of needle 20.
- first stopper 28 is located in lumen 18 near first end 14 of tubular member 12.
- the medicament is contained in lumen 18 of tubular member 12.
- the boundaries of the medicament are defined by tubular member 12 in the longitudinal axis and first stopper 28 at first end 14 and membrane 26 at second end 16.
- the portion of membrane 26 covering piercing end 22 of needle 20 has a dome-like shape.
- Medicament cartridge 10 is contained in an injection device (not shown) so that second stopper 30 at second end 16 cannot be pushed away from medicament cartridge 10. Shoulder 42, which contacts second end 16 of tubular member 12 when anchored in the injection device, prevents second stopper 30 from detaching from tubular member 12 as the result of the movement of first stopper 28.
- first stopper 28 continues to slide within lumen 18 until surface 38 of first stopper 28 contacts second stopper 30.
- the present invention encompasses any manner of causing compression of the medicament. Relative movement between first and second stoppers 28, 30 would result in compression of the medicament. Compression could be caused, for example, by movement of second stopper 28 toward first end 14 of tubular member 12. One mechanism that could cause this movement is twisting or pushing second stopper 30 toward first stopper 28 to further "seat" second stopper 30.
- Figures 5-7 show another embodiment of a medicament cartridge according to the present invention in which the flexible member is a cap 46 with a base 48 extending therefrom.
- Base 48 has a collapsible portion 50 that flexes upon application of a pressure.
- the compression of medicament in lumen 18 between first stopper 28 and cap 46 causes collapsible portion 50 to flex sufficiently so that piercing end 22 of needle 20 pierces cap 46 to create a fluid pathway for the medicament through needle 20.
- Cap 46 has a dimple 52 that mates with medicament contacting surface 38 of first stopper 28 to minimize volume of medicament remaining in lumen 18 after completion of the injection.
- Dimple 52 also reduces the cross section of cap 46 that must be pierced by piercing end 22.
- a number of materials, including polymers and elastomers, can be used for the flexible member (membrane 26 or cap 46 and base 48) as long as: (1) the flexible member can be punctured by piercing end 22; (2) the flexible member has the desired flexibility; (3) the flexible member is compatible with the medicament; and (4) possesses the appropriate barrier properties required for a drug container.
- piercing end 22 of needle 20 is shown having a beveled end, any geometry capable of piercing membrane 26 can be used.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00980229A EP1225939A4 (fr) | 1999-10-22 | 2000-10-20 | Cartouche de medicament |
AU17521/01A AU1752101A (en) | 1999-10-22 | 2000-10-20 | Medicament cartridge |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16087699P | 1999-10-22 | 1999-10-22 | |
US60/160,876 | 1999-10-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001030423A1 true WO2001030423A1 (fr) | 2001-05-03 |
Family
ID=22578841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/029111 WO2001030423A1 (fr) | 1999-10-22 | 2000-10-20 | Cartouche de medicament |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1225939A4 (fr) |
AU (1) | AU1752101A (fr) |
WO (1) | WO2001030423A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003015853A1 (fr) * | 2001-08-07 | 2003-02-27 | Riemser Arzneimittel Ag | Ampoule pour dispositif d'injection |
FR2832080A1 (fr) * | 2001-11-15 | 2003-05-16 | Valois Sa | Dispositif de distribution de produit fluide |
AT500941A1 (de) * | 2004-11-09 | 2006-05-15 | Arrowmind Patententwicklungs U | Injektionsvorrichtung mit einer karpule zur aufnahme eines medikamentes, sowie karpule zum einsatz in eine injektionseinrichtung |
US9504816B2 (en) | 2008-03-17 | 2016-11-29 | Syringetech Llc | Multi-mode syringe |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116319A (en) * | 1988-08-26 | 1992-05-26 | Advanced Protective Injection Systems B.V. | Safety device for an injection syringe needle |
US5855839A (en) * | 1995-05-04 | 1999-01-05 | Sanofi (S.A.) | Process for manufacturing an injection device of the pre-filled type containing a dose of liquid for injection and injection device produced |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1288174A (en) * | 1918-06-28 | 1918-12-17 | H K Mulford Company | Package and hypodermic syringe. |
DE882600C (de) * | 1951-12-04 | 1953-07-09 | Alfons Kiesl | Spritzampulle |
US3308821A (en) * | 1964-03-23 | 1967-03-14 | Walter A Shields | Disposable hypodermic syringes |
US4051850A (en) * | 1975-11-21 | 1977-10-04 | Tischlinger Edward A | Disposable medicament injector |
US4072149A (en) * | 1976-08-09 | 1978-02-07 | Tischlinger Edward A | Nose cap and diaphragm assembly for injector |
US4171698A (en) * | 1977-08-15 | 1979-10-23 | Abbott Laboratories | Prefilled two-compartment syringe |
-
2000
- 2000-10-20 WO PCT/US2000/029111 patent/WO2001030423A1/fr not_active Application Discontinuation
- 2000-10-20 AU AU17521/01A patent/AU1752101A/en not_active Abandoned
- 2000-10-20 EP EP00980229A patent/EP1225939A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116319A (en) * | 1988-08-26 | 1992-05-26 | Advanced Protective Injection Systems B.V. | Safety device for an injection syringe needle |
US5855839A (en) * | 1995-05-04 | 1999-01-05 | Sanofi (S.A.) | Process for manufacturing an injection device of the pre-filled type containing a dose of liquid for injection and injection device produced |
Non-Patent Citations (1)
Title |
---|
See also references of EP1225939A4 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003015853A1 (fr) * | 2001-08-07 | 2003-02-27 | Riemser Arzneimittel Ag | Ampoule pour dispositif d'injection |
FR2832080A1 (fr) * | 2001-11-15 | 2003-05-16 | Valois Sa | Dispositif de distribution de produit fluide |
WO2003041872A1 (fr) | 2001-11-15 | 2003-05-22 | Valois Sas | Dispositif de distribution de produit fluide |
US8419706B2 (en) | 2001-11-15 | 2013-04-16 | Aptar France Sas | Fluid product dispensing device |
AT500941A1 (de) * | 2004-11-09 | 2006-05-15 | Arrowmind Patententwicklungs U | Injektionsvorrichtung mit einer karpule zur aufnahme eines medikamentes, sowie karpule zum einsatz in eine injektionseinrichtung |
US9504816B2 (en) | 2008-03-17 | 2016-11-29 | Syringetech Llc | Multi-mode syringe |
Also Published As
Publication number | Publication date |
---|---|
EP1225939A1 (fr) | 2002-07-31 |
AU1752101A (en) | 2001-05-08 |
EP1225939A4 (fr) | 2003-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1092444B1 (fr) | Dispositif d'administration intradermique et ensemble aiguille | |
US10610647B2 (en) | Syringe assembly with pivoting plunger and integral tip guard | |
EP2453957B1 (fr) | Dispositif d'injection à raccord luer étanche | |
EP1225938B1 (fr) | Carpule de medicament et dispositif d'injection | |
CN110325231B (zh) | 用于注射药物的设备和方法 | |
CN107405455B (zh) | 笔式针组件 | |
EP1703931B1 (fr) | Seringue de rin age a deplacement positif | |
CN101370544B (zh) | 一种安全针头 | |
US6746420B1 (en) | Parenteral apparatus | |
EP4088763A1 (fr) | Dispositif d'administration de médicaments | |
EP2542282B1 (fr) | Dispositif d'injection | |
EP3634544B1 (fr) | Dispositifs d'injection | |
EP1225939A1 (fr) | Cartouche de medicament | |
US20230310756A1 (en) | Injection device | |
AU2005220193B2 (en) | Intradermal delivery device including a needle assembly | |
EP2023984A2 (fr) | Dispositif protecteur pour aiguille hypodermique | |
WO2022089940A1 (fr) | Récipient médical pour stocker un médicament liquide | |
AU755381B2 (en) | A parenteral apparatus | |
AU2012267161A1 (en) | Injection device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000980229 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000980229 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000980229 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |